Obesity-drug maker Metsera Inc.'s stock jumped 47% on Friday as the biggest gainer among three initial public offerings bucking a swoon in the equity market to rise in their stock-market debuts Friday ...

Roche’s PATHWAY HER2 (4B5) test helps identify patients with HER2-ultralow breast cancer, who may be eligible for targeted ...

Journavx is designed to eliminate the risks of addiction and overdose associated with medications like Vicodin and OxyContin.

The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...

February is observed as American Heart Month, a period dedicated to raising awareness about heart health. The first American Heart ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

The U.S. Food and Drug Administration (FDA) said on Thursday it had identified three cybersecurity risks associated with ...

The FDA has approved Ozempic to reduce kidney failure risk in people with type 2 diabetes and chronic kidney disease. Studies ...

Medtech supplier Cortland Biomedical said the new designation positions it as a full-service contract manufacturer.

Here are three recent recalls reported to the FDA: ...

The FDA warned the nation about the growing vulnerability of the medical device supply chain and its effects on public health, particularly among pediatric patients, in a Jan. 16 news release.

Wondering what the best class is in Path of Exile 2? Path of Exile 2 features six character classes in Early Access, and each boasts a wide array of builds that are sure to test the mettle of any ARPG ...